Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 7Unspecified Adult Solid Tumor, Protocol Specific 5Retinoblastoma 3Solid Tumors 2Sarcoma 2Mesothelioma 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Solid Tumours 1Solid Tumor 1Small Cell Lung Carcinoma 1Rhabdomyosarcoma 1Retinal Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Pheochromocytoma 1Peritoneal Neoplasms 1Pelvic Neoplasms 1Ovarian Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasm Metastasis 1Medulloblastoma 1Lung Neoplasms 1Liver Neoplasms 1Liposarcoma 1Head and Neck Neoplasms 1HER2-negative Breast Cancer 1

Interventions

AZD 6244 5GSK 1363089 3molibresib 2pazopanib 1ispinesib 1enzalutamide 1brigimadlin 1abiraterone 1Topotecan 1SLC-0111 1Rifampin 1Prednisone 1Omeprazole 1Moxifloxacin 1Midazolam 1Itraconazole 1Granisetron 1Fluconazole 1Famotidine 1Doxorubicin 1Cytochrome P-450 CYP3A 1Cytochrome P-450 CYP2C19 1Cytochrome P-450 CYP1A2 1Carboplatin 1Carbon-14 1Caffeine 1CH5183284 1BGC945 12-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumours × Doxorubicin × Other solid neoplasm × Clear all
NCT06815575 2025-12-17

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

Racura Oncology Ltd

Phase 1 Recruiting
53 enrolled
Other solid neoplasm

Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡